Sandoz has delivered its first results as a standalone company, reporting overall growth of 5% – and 6% at constant currencies – for the first nine months of 2023.
Key Takeaways
-
Sandoz has reported sales growth of 5% (+6% cc) to $7.10bn in the first nine months of 2023.
Reporting the results just a few weeks after its 4 October spinoff from former parent company Novartis, Sandoz highlighted that...







